Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| PHILIP MORRIS INTERNATIONAL, INC. | PM | Nyse +11 Other | 4,681,344 |
99.83
USD
 | Stock | |
| PHILIP MORRIS INTERNATIONAL, INC. | PMI | Swiss Exchange | 255 |
90
CHF
| ||
| PHILIP MORRIS INTERNATIONAL, INC. | 4I1 | Deutsche Boerse AG | 232 |
92.07
EUR
| ||
| PHILIP MORRIS INTERNATIONAL, INC. | 0M8V | London S.E. | 0 |
96.5
USD
| ||
| PHILIP MORRIS INTERNATIONAL INC. | PMOR | Wiener Boerse | - |
92.23
EUR
| ||
| PHILIP MORRIS INTERNATIONAL, INC. | 4I1 | Börse Stuttgart | - |
91.84
EUR
| ||
| PHILIP MORRIS INTERNATIONAL, INC. | 4I1 | Frankfurt | 1,638 |
92.28
EUR
| ||
| PHILIP MORRIS INTERNATIONAL INC. | PM * | Mexican S.E. | 125 |
1,700
MXN
| ||
| PHILIP MORRIS INTERNATIONAL, INC. | 4I1 | BOERSE MUENCHEN | 395 |
91.96
EUR
| ||
| PHILIP MORRIS INTERNATIONAL INC. | 4PM | Borsa Italiana | - |
91.99
EUR
| ||
| PHILIP MORRIS INTERNATIONAL INC. | 4I1 | Bulgaria S.E. | - |
92.66
EUR
| ||
| PHILIP MORRIS INTERNATIONAL, INC. | PMI | Berne S.E. | - | - CHF
| ||
| PHILIP MORRIS INTERNATIONAL, INC. | PHMO34 | Sao Paulo | 98 |
257.7
BRL
| Stock | |
| PHILIP MORRIS CR | TABAK | Prague S.E. +5 Other | 760 |
14,900
CZK
| Stock | |
| PHILIP MORRIS CR A.S. | 0MV4 | London S.E. | 0 |
15,800
CZK
| ||
| PHILIP MORRIS CR A.S. | TBK | Deutsche Boerse AG | - |
596
EUR
| ||
| PHILIP MORRIS CR A.S. | TBK | Börse Stuttgart | 2 |
587
EUR
| ||
| PHILIP MORRIS CR A.S. | TBK | BOERSE MUENCHEN | 19 |
596
EUR
| ||
| PHILIP MORRIS CR A.S. | PHPMF | OTC Markets | 0 |
640.5
USD
| ||
| PHILIP MORRIS (PAKISTAN) LIMITED | PMPK | Pakistan S.E. | 261 |
610
PKR
| Stock | |
| PHILIP MORRIS OPERATIONS A.D. NIS | DINN | Belgrade S.E. | 11 |
7,010
RSD
| Stock | |
| PHILIP MORRIS OPERATIONS A.D. NIS | DINNPB | Belgrade S.E. | 46 |
7,600
RSD
| Stock | |
| PHILIP MORRIS - DIVIDEND (VD8) - ELA/20270115 | Euronext Amsterdam | - |
5.54
USD
| Future | ||
| PHILIP MORRIS - DIVIDEND (VD8) - ELA/C2 | Euronext Amsterdam | - |
5.42
USD
| Future | ||
| PHILIP MORRIS - DIVIDEND (VD8) - ELA/C3 | Euronext Amsterdam | - |
5.54
USD
| Future | ||
| PHILIP MORRIS - DIVIDEND (VD8) - ELA/20250117 | Euronext Amsterdam | - |
5.3
USD
| Future |
News (126)
Companies (45)
Philip Morris International, Inc. is one of the world leading producers of cigarettes and tobacco products. In 2023, the group sold 612.9 billion cigarettes (under the brand names Marlboro, Parliament, Chesterfield, L&M, Bond Street, Philip Morris, Next, ...
Philip Morris International, Inc. is one of the world leading producers of cigarettes and tobacco products. In 2023, the group sold 612.9 billion cigarettes (under the brand names Marlboro, Parliament, Chesterfield, L&M, Bond Street, Philip Morris, Next, ...
Altria Group, Inc. is a holding company organized around three sectors of activity: - manufacturing of tobacco products (88.9% of net sales): cigarettes (brands Marlboro, L&M, Philip Morris, Chesterfield, etc.), cigars (Black & Mild), and pipe tobacco; ...
Altria Group, Inc. is a holding company organized around three sectors of activity: - manufacturing of tobacco products (88.9% of net sales): cigarettes (brands Marlboro, L&M, Philip Morris, Chesterfield, etc.), cigars (Black & Mild), and pipe tobacco; ...
Altria Group, Inc. is a holding company organized around three sectors of activity: - manufacturing of tobacco products (88.9% of net sales): cigarettes (brands Marlboro, L&M, Philip Morris, Chesterfield, etc.), cigars (Black & Mild), and pipe tobacco; ...
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages ad ...
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages ad ...
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages ad ...
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages ad ...
Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, ...
Insiders
Philip Edward Yea is a British businessperson who has been at the helm of 11 different companies and is Chairman of Mondi Plc, Chairman at Mondi Ltd. (a subsidiary of Mondi Plc), Independent Non-Executive Chairman of Equiniti Group Plc and Chairman for Farm Street Advisors Ltd. Mr. Yea is also on the board of Marshall of Cambridge (Holdings) Ltd., The Francis Crick Institute Ltd. and 27 Farm Street Management Co. Ltd. and Member of The Chartered Institute of Management Accountants. In the past Philip Edward Yea occupied the position of Chairman for The Rose Partnership LLP, Chief Executive Officer at 3i Group Plc, Finance Director & Director at Diageo Plc Finance Director at Grand Metropolitan Plc and Finance Director for Guinness Plc (both are subsidiaries of Diageo Plc), Chairman at Leica Geosystems AG, Non-Executive Chairman at bwin.party digital entertainment Plc, Chairman for Greene King Ltd., Chairman for Majid Al Futtaim Properties LLC, Managing Director at Investcorp SA and Chairman for British Heart Foundation. Mr. Yea received an undergraduate degree from the University of Oxford.
Darryl J.
Yea is currently the President & Director at Invesco Capital Management, Inc. and an Independent Director at Railtown II Capital Corp.
He has also served as a Director at various companies including Genix Pharmaceuticals Corp., OneMove Technologies, Inc., and Corazon Gold Corp.
Yea received his undergraduate degree from the University of British Columbia.
Kevin Yea worked as a Principal at PricewaterhouseCoopers (Oman).
Prior to that, he obtained an undergraduate degree from Brigham Young University in 2002.
No results for this search
- Stock Market
- Advanced search
- Philip Yea
